Lind Lab

Main Research Focus:
Our main focus is in the development of polyunsaturated fatty acids and metal ionophores as anticancer agents; hemostasis and thrombosis.

Recent Publications 

Ding WQ, Vaught JL, Yamauchi H, Lind SE.  Differential sensitivity of cancer cells to docosahexaenoic acid (DHA)-induced cytotoxicity: the potential importance of down-regulation of SOD1 expression. Molecular Cancer Therapeutics. 3:1109-1117, 2004

Ding WQ, Liu B, Vaught JL Yamauchi H and Lind SE. Anti-cancer activity of the antibiotic clioquinol. Cancer Res 65:3389-3395, 2005.

Huang X, Ding WQ, Vaught J, Wolf R, Morrissey JH, Harrison RG, Lind SE.  A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties.  Blood. 107:980-986, 2006.

Ding WQ, Liu B, Vaught JL, Palmiter RD, Lind SE. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Molecular Cancer Therapeutics.5:1864-1872, 2006.

Ding WQ, Lind SE. Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity. Molecular Cancer Therapeutics. 6:1467-1474, 2007.

Lab Personnel

Stuart E. Lind, MD – Professor, PI
Jung Song Park, PhD – Senior Instructor
Evan Kim, BS - PRA